NCT00590265View on ClinicalTrials.gov

Light-Therapy in the Treatment of the Acute Phase of the Bipolar Type II Depression

NAActive, not recruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

January 31, 2008

Primary Completion Date

June 30, 2025

Study Completion Date

August 31, 2026

Conditions
Bipolar Type II DisorderDepression, Bipolar
Interventions
DEVICE

Northern Light Technology (SADelite lamp) bright light-therapy

10 000 lux for 30 minutes

DEVICE

Northern Light Technology (SADelite lamp) Dim light-therapy

\<100 lux for 30 minutes

Trial Locations (1)

H4H 1R3

Douglas Mental Health University Institute, Montreal

All Listed Sponsors
collaborator

National Alliance for Research on Schizophrenia and Depression

OTHER

lead

Douglas Mental Health University Institute

OTHER

NCT00590265 - Light-Therapy in the Treatment of the Acute Phase of the Bipolar Type II Depression | Biotech Hunter | Biotech Hunter